Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Return on Equity: 2023-2025

Historic Return on Equity for InMed Pharmaceuticals (INM) over the last 3 years, with Jun 2025 value amounting to 0.72%.

  • InMed Pharmaceuticals' Return on Equity rose 12.00% to 0.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.66%, marking a year-over-year increase of 12.00%. This contributed to the annual value of 0.72% for FY2025, which is 0.00% changed from last year.
  • Latest data reveals that InMed Pharmaceuticals reported Return on Equity of 0.72% as of FY2025, which was down 0.02% from 0.72% recorded in FY2024.
  • Over the past 5 years, InMed Pharmaceuticals' Return on Equity peaked at 0.72% during FY2024, and registered a low of 0.75% during FY2023.
  • For the 3-year period, InMed Pharmaceuticals' Return on Equity averaged around 0.73%, with its median value being 0.72% (2025).
  • Its Return on Equity has fluctuated over the past 5 years, first grew by 3bps in 2024, then fell by 0bps in 2025.
  • MRY analysis of 3 years shows InMed Pharmaceuticals' Return on Equity stood at 0.75% in 2023, then rose by 4bps to 0.72% in 2024, then fell by 0bps to 0.72% in 2025.
  • Its Return on Equity was 0.72% in FY2025, compared to 0.72% in FY2024 and 0.75% in FY2023.